Menovo(SH:603538) Ge Long Hui A P P·2026-02-12 08:40Core Viewpoint - Meinuohua's subsidiary, Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd., is participating in the national organized procurement for drugs whose agreements have expired, with ten products expected to be selected for this procurement [1] Group 1: Procurement Participation - The company is involved in the bidding for the continuation of procurement for drugs that are part of the first to eighth batches of the national organized procurement agreements that have expired [1] - The expected selected products include Perindopril tert-butylamine tablets, Clopidogrel hydrogen sulfate tablets, and Empagliflozin tablets among others [1] Group 2: Procurement Timeline - The results of the procurement selection are anticipated to be implemented by the end of March 2026 [1] - The procurement cycle for the selected drugs will last from the actual execution date of the selection results until December 31, 2028 [1] Group 3: Procurement Prioritization - During the procurement cycle, medical institutions will prioritize the use of the drugs selected in this continuation procurement and ensure the completion of the agreed procurement volume [1]